vocacapsaicin

Small moleculeexperimental

Clinical trial activity

7 trials · 3 clinical orgs · 0 marketing orgs

Phase 1
3
Phase 2
6
Phase 3
0
Phase 4
0

Earliest trial started Nov 2, 2017 (NCT03307837)

Timeline

2010s

  1. Jan 1, 2017

    Earliest Phase 1 Sponsor(trial)

  2. Jan 1, 2018

    Earliest Phase 2 Sponsor(trial)

Indications

Mechanism of action

Chemistry & pharmacology

Loading structure…

SMILES

CNCC1CCCCN1C(=O)Oc1ccc(CNC(=O)CCCC/C=C/C(C)C)cc1OC
Mol. weight
459.63 g/mol
Lipinski Ro5
Pass
Rule of 3
No
Chirality
Racemic Mixture
Inorganic
No
Polymer
No

Oral

No

Parenteral

No

Topical

No

Prodrug

Sources

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT04774328Phase 1/Phase 2 (Phase 2)Feb 10, 2021Concentric Analgesics
NCT04203537Phase 1/Phase 2 (Phase 2)Dec 4, 2019Concentric Analgesics, HD Research
NCT03885596Phase 2Mar 25, 2019Concentric Analgesics
NCT03789318Phase 2Dec 3, 2018Concentric Analgesics, Lotus Clinical Research
NCT03731364Phase 2Oct 29, 2018Concentric Analgesics
NCT03599089Phase 2Jul 9, 2018Concentric Analgesics
NCT03307837Phase 1Nov 2, 2017Concentric Analgesics
Showing 7 of 7 trials
Page 1 / 1

Organizations

Research & Development (3)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Concentric AnalgesicsFor profit7722017
HD ResearchAcademic/Hospital1012019
Lotus Clinical ResearchFor profit1012018
3 organizations
Page 1 / 1